An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism

Semin Thromb Hemost. 1989 Oct;15(4):424-34. doi: 10.1055/s-2007-1002742.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Review

MeSH terms

  • Bone and Bones / surgery
  • Dihydroergotamine / therapeutic use
  • Drug Evaluation
  • Drug Therapy, Combination
  • Fibrinolytic Agents / therapeutic use*
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Multicenter Studies as Topic
  • Postoperative Complications / prevention & control
  • Pulmonary Embolism / prevention & control
  • Randomized Controlled Trials as Topic
  • Thromboembolism / prevention & control*

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Dihydroergotamine